This page includes the latest FDA filings for Portola Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | PTLA | DUNS 142296016 |
Device Company | Device | Date |
|---|---|---|
| Portola Pharmaceuticals, Inc., Patheon, Inc., AndersonBrecon Inc. | Prescription Medication | 2019-08-01 |
| Portola Pharmaceuticals, Inc., Patheon, Inc., AndersonBrecon Inc. | Prescription Medication | 2019-04-03 |
| Portola Pharmaceuticals, Inc. | BEVYXXA | 2017-07-07 |
| Portola Pharmaceuticals, Inc. | BEVYXXA | 2017-07-07 |
| NCAGE Code | 5XNN2 | PORTOLA PHARMACEUTICALS, INC. |
| CAGE Code | 5XNN2 | PORTOLA PHARMACEUTICALS, INC. |
| S.A.M. Registration | 5XNN2 [142296016] | PORTOLA PHARMACEUTICALS, INC. |
| SEC | 0001269021 | PORTOLA PHARMACEUTICALS INC of DELAWARE |